Larry Robbins' hedge fund firm, Glenview Capital, is out with its fourth quarter letter to investors. Glenview's Opportunity Fund returned 25.25% net in 2014.
In the letter, Robbins outlines his thesis on auto dealers (Group 1 Automotive ~ GPI), Flextronics (FLEX), McDonald's (MCD), PHH (PHH), T-Mobile (TMUS), and pharma roll-up plays like Actavis (ACT) and Endo (ENDP).
Glenview's Q4 Letter Takeaways
On McDonald's (MCD): This is a new stake for Glenview and they feel there's basically 5 ways to make a 'happy meal' to help the company: operational turnaround, SGA rationalization, refranchising, additional leverage, and real estate. They feel this could trade as high as $169 (currently trades around $99.)
On MCD, Robbins writes, "Fundamentally, McDonald’s has a number of characteristics that we look for in good businesses. Approximately 75% of EBITDA is driven by royalties and rent, which is a secure, stable earnings stream free of operating leverage. Food, in general, is a defensive end market, and McDonald’s positioning at the value end of the spectrum provides further insulation from material cyclicality as evidenced by positive same store sales in the U.S. and positive consolidated EPS growth in every year throughout the last recession."
On T-Mobile (TMUS): Glenview has owned this company since 2013 but bought more shares in December 2014. They feel the company has a few positive things going for it to continue its growth: aggressively going after new subscribers, deploying spectrum to address new customers, and seeing positive FCF generation this year.
They also like that the company is a "key strategic asset" and that their parent company Deutsche Telekom is looking to sell. Glenview feels TMUS could either: try to tie-up with Dish Network and their spectrum, seek a sale to a foreign buyer, or again try to merge with Sprint once a new political administration takes office in 2016.
Embedded below is Glenview's Q4 letter:
For more from this hedge fund, yesterday we posted up some more of Glenview's recent portfolio activity.
Wednesday, March 25, 2015
Glenview Capital Q4 Letter on McDonald's, T-Mobile, Auto Dealers & More
Tuesday, October 28, 2014
Larry Robbins' Presentation at Capitalize For Kids Sohn Canada
We're posting up notes from the Capitalize For Kids Sohn Canada conference that just took place. Next up is Larry Robbins of Glenview Capital who pitched a few stock ideas.
Larry Robbins' Sohn Canada Presentation
Looks for companies with excess cash on the balance sheet (cost of cash capital is low), debt capacity (companies with tangible assets and good credit history to leverage up), incremental debt capacity (under levered relative to industry and can leverage up without jeopardizing current credit rating) and finally defensive growth which protects the investor if company takes on leverage.
Pitched LONG on Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Endo International PLC (ENDP), and Actavis (ACT), which all fall under the criteria mentioned above.
Be sure to check out the rest of the presentations from Capitalize For Kids Sohn Canada here.
Wednesday, March 5, 2014
What We're Reading ~ Analytical Links 3/5/14
The 1-hour China Book: Peking University professors explain China business [Jeff Towson]
Investing's biggest irony: everyone thinks they're a contrarian [Morgan Housel]
Summary of Warren Buffett's long CNBC appearance this week [Brooklyn Investor]
Buffett tells investors to get real about EBITDA [Herb Greenberg]
A new form of shareholder activism gains momentum [Dealbook]
A look at Platform Specialty Products [Seeking Alpha]
The decline of department store sales [USNews]
VRX, ENDP, ACT: Will pharmaceutical roll-ups end badly? [Value Institute]
House with a modified loan is symbol of servicers' tug of war with investors [Dealbook]
You won't have broadband competition without regulation [Reuters]
On Carlos Slim's challenge to his telecom dominance [Economist]
America should make life easier, not harder, for activist investors [Economist]
Digital habits: Nielsen profiles the US consumer [TNooz]
The future of the news business [Marc Andreessen]
How and why to keep a 'commonplace book' [RyanHoliday]
Friday, May 10, 2013
Blue Ridge Capital Starts Endo Health Solutions (ENDP) Position
John Griffin's hedge fund firm Blue Ridge Capital filed a 13G with the SEC and just disclosed a 5.98% ownership stake in Endo Health Solutions (ENDP) with 6,635,000 shares.
This is a brand new position for the hedge fund as they did not report a stake at the end of 2012 in the last portfolio disclosures. The filing was required due to portfolio activity on April 30th.blue rid
Per Google Finance, Endo Health is "a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel."